What order should be placed for 25% human albumin infusion after a large-volume paracentesis (more than 5 L of ascitic fluid removed)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Albumin Order for Large-Volume Paracentesis (>5 L)

Order 25% human albumin at a dose of 6-8 grams per liter of ascitic fluid removed, administered intravenously at the time of or immediately following the paracentesis procedure. 1, 2

Dosing Algorithm

For practical ordering purposes, use this tiered approach based on volume removed 2:

  • 5-6 L removed: Order 40-48 g (approximately 50 g or two 25 g vials of 25% albumin)
  • 7-8 L removed: Order 56-64 g (approximately 50-75 g)
  • >8 L removed: Order 6-8 g per liter (e.g., 72-80 g for 10 L)

The 2021 AASLD guidance explicitly states that after 5 L removal, approximately 40 g should be infused, and after 8 L removal, approximately 64 g should be given 2.

Critical Considerations

Volume threshold matters: The risk of postparacentesis circulatory dysfunction (PPCD) increases significantly when >8 L is removed in a single session 2. Consider limiting paracentesis to <8 L per session when feasible, though complete drainage with appropriate albumin replacement remains safe 1, 3.

Special populations requiring higher doses: Patients with acute-on-chronic liver failure (ACLF) should receive 6-8 g/L regardless of the volume removed 1. This represents a distinct recommendation from standard cirrhotic ascites.

Timing and Administration

Albumin should be administered at the time of paracentesis 1. The FDA labeling confirms intravenous administration is required, and the solution is ready to use without dilution 4. The infusion can be given during or immediately after the procedure—both approaches are supported.

Evidence Quality

The recommendation is based on high-quality RCT data showing that albumin administration prevents acute kidney injury (21% incidence without albumin vs 0% with albumin in daily 5-L paracenteses) and prevents activation of the renin-angiotensin-aldosterone system 1. A 2026 national cohort study of 56,941 outpatient paracentesis procedures confirmed that albumin reduces AKI-related hospitalizations (OR 0.66), with greater benefit in patients with lower eGFR 5.

Lower Dose Controversy

Recent evidence suggests lower doses (≤6 g/L) may be as effective as standard dosing 6, 7. One study showed 6.5 g/L versus 8.3 g/L had equivalent outcomes for hyponatremia, renal impairment, and hypotension 6. However, guidelines have not yet changed to reflect this, and the standard 6-8 g/L remains the recommended dose 1, 2.

Common Pitfalls to Avoid

  • Don't skip albumin for "only" 5 L: The threshold is >5 L, meaning 5.1 L qualifies for albumin replacement
  • Don't use crystalloids alone: These worsen interstitial edema without addressing oncotic deficit 4
  • Don't underdose in ACLF: These patients need full 6-8 g/L even for smaller volume taps 1
  • Monitor for fluid overload: Though rare, pulmonary edema can occur, particularly in patients with cardiac dysfunction 1

Practical Order Example

"25% human albumin 50 g IV (for 6-7 L removed) to be given during or immediately after large-volume paracentesis"

Adjust the total grams based on actual volume removed using the 6-8 g/L calculation.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.